Seeing Is Believing
Healthcare - Sector
ATRA is currently covered by 2 analysts with an average price target of $15.5. This is a potential upside of $6.27 (67.93%) from yesterday's end of day stock price of $9.23.
Atara Biotherapeutics's activity chart (see below) currently has 73 price targets and 97 ratings on display. The stock rating distribution of ATRA is 75% BUY and 25% HOLD.
Analysts average stock forecasts to be materialized ratio is 57.21% with an average time for these price targets to be met of 203.05 days.
Highest price target for ATRA is $18, Lowest price target is $13, average price target is $15.5.
Most recent stock forecast was given by from CANACCORD on 08-May-2026. First documented stock forecast 03-Dec-2015.
Currently out of the existing stock ratings of ATRA, 3 are a BUY (75%), 1 are a HOLD (25%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 08-May-2026
$13
$2.49 (23.69%)
$6
5 months 1 days ago
(08-May-2026)
5/7 (71.43%)
$4.66 (55.88%)
542
Buy Since 18-Aug-2025
$18
$7.49 (71.27%)
$16
10 months 18 days ago
(21-Nov-2025)
4/6 (66.67%)
$4.32 (31.58%)
167
Hold Since 22-May-2024
1 years 8 months 11 days ago
(28-Jan-2025)
2/6 (33.33%)
$437.5 (129.63%)
149
Hold Since 02-Nov-2023
$5
$-5.51 (-52.43%)
$10
1 years 8 months 18 days ago
(21-Jan-2025)
3/5 (60%)
$-1.05 (-17.36%)
310
Buy Since 30-May-2019
$7
$-2.48 (-26.16%)
$25
1 years 8 months 18 days ago
(21-Jan-2025)
1/6 (16.67%)
$0.95 (15.70%)
3
What is ATRA (Atara Biotherapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on ATRA (Atara Biotherapeutics)?
Which analyst has the most public recommendations on ATRA (Atara Biotherapeutics)?
Which analyst is the currently most bullish on ATRA (Atara Biotherapeutics)?
Which analyst is the currently most reserved on ATRA (Atara Biotherapeutics)?